Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety

Figure 2

Active ingredients of PBCRBSCMs with antiplatelet effect. (a) Tanshinone IIA, (b) tetramethylpyrazine, (c) paeoniflorin, (d) salvianolic acid B, and (e) notoginsenoside Fc.

(a)

(b)

(c)

(d)

(e)